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Abstract It has been long appreciated that protective
immunity against fungal pathogens is dependent on
activation of cellular adaptive immune responses repre-
sented by T lymphocytes. The T-helper (Th)1/Th2 para-
digm has proven to be essential for the understanding of
protective adaptive host responses. Studies that have
examined the significance of regulatory T cells in fungal
infection, and the recent discovery of a new T-helper subset
called Th17 have provided crucial information for under-
standing the complementary roles played by the various T-
helper lymphocytes in systemic versus mucosal antifungal
host defense. This review provides an overview of the role
of the various T-cell subsets during fungal infections and
the reciprocal regulation between the T-cell subsets con-
tributing to the tailored host response against fungal
pathogens.
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Introduction
The spectrum of fungal infections ranges from superficial
skin infection to lethal invasive disease. Pathogenic fungi
cause different clinical syndromes dependent on the
location of infection, virulence, and host status. Dermato-
phytes such as Trichophyton rubrum are acquired by direct
contact and can cause superficial infection of the skin and
nails in immunocompetent patients. Candida albicans is a
commensal that can be efficiently controlled by the immune
system in normal conditions, but when the immune system
becomes compromised, it can cause invasive disease.
Filamentous fungi such as Aspergillus spp. are inhaled
and in certain conditions will induce an allergic reaction in
the lungs known as allergic bronchopulmonary aspergillosis
(ABPA), whereas in a neutropenic host they can cause
lethal disease. These differences illustrate the large spec-
trum of infections caused by pathogenic fungi and justify
the need to induce tailored innate and/or adaptive immune
responses to overcome infection.
T lymphocytes represent an important component of host
defense against fungal pathogens, as reflected by the fact
that patients with AIDS who lack CD4+ T cells are highly
susceptible to C. albicans, Aspergillus fumigatus, Crypto-
coccus neoformans, Histoplasma capsulatum, and Pneumo-
cystis jiroveci. This review focuses on our current
knowledge about the role of T-cell subsets in antifungal
host defenses.
T-cell Subsets
Mosmann and Coffman [1] introduced the concept of
different sets of T-helper (Th) cells defined on the basis of
their function, especially the types of cytokines secreted by
each of them. The so-called Th1 cells are characterized by
the production of interferon-γ (IFNγ), which is essential
for defense against intracellular pathogens, whereas Th2
cells are characterized by the production of interleukin (IL)-
4 and are mainly important in allergic disease and host
defenses against parasitic infections. Recently, a new subset
of T-helper cells has been described, called Th17 cells, and
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cytokine profile, namely IL-17A, IL-17F, IL-21, and IL-22.
IL-17A is important for neutrophil recruitment and host
defense against extracellular bacteria and fungi. The
development of specific T-helper cells from naïve CD4+
T cells is dependent on antigen presentation by professional
antigen-presenting cells, engagement of costimulatory
molecules, and a specific cytokine milieu. The cytokines
IL-23, IL-1β, IL-6, and transforming growth factor (TGF)-
β induce the development of Th17 cells; IL-12 and IL-18
are important for Th1 differentiation; and IL-4 drives naïve
T cells toward a Th2 phenotype.
In addition to the T-helper activating lymphocytes, other
important subsets of T cells are the regulatory T cells
(Tregs) and the CD8+ lymphocytes. Tregs serve an
important function in host responses by controlling
pathogen-specific immune responses and keeping autor-
eactivity in check. CD8+ T cells play an important role in
infectious diseases by producing cytokines, They are also
able to directly kill cells—hence the name cytotoxic T-cells.
CD8+ T cells recognize peptides derived from pathogens
that are presented by MHC class I molecules, and in this
way are able to target cells that are infected. In contrast to
conventional αβ T cells, γδ T cells are preferentially
localized in nonlymphoid tissues such as the lungs and
intestine, and their localization and function suggests an
important role in the first line of innate host defense.
Th1 Cells
IFNγ produced by Th1 lymphocytes is important for
stimulation of antifungal activity of neutrophils. The central
role of endogenous IFNγ in the resistance against systemic
fungal infection is underscored by the observation that
knockout mice deficient in IFNγ are highly susceptible to
disseminated C. albicans infection [2]. In addition, mice
deficient in IL-18, which plays a crucial role in the induction
of IFNγ, are also more susceptible to disseminated candidi-
asis [3]. IFNγ can also contribute to anti-Candida host
defense by inducing nitric oxide (NO) production by
macrophages, as well as Candida-specific immunoglobulin
production [4]. Furthermore, it is well known that the
incidence of oropharyngeal candidiasis is very high in
patients with HIV who have low CD4+ counts and thus
low Th1 responses. These data reflect the importance of Th1
cells in anti-Candida host defenses.
IFNγ also appears to be protective in the host defense
against Aspergillus. Cells producing IFNγ are induced by
Aspergillus in immunocompetent mice. Live conidia that
undergo swelling and germination are able to prime Th1
responses [5]. It has been elegantly demonstrated that CD4+
T cells differentiate during respiratory fungal infection, with
Toll-like receptor–mediated signals in the lymph node enhanc-
ing the potential for IFNγ production, whereas other signals
promote Th1differentiation inthe lung [6]. In a well-designed
study, adoptive transfer of dendritic cells pulsed with
Aspergillus conidia increased resistance to invasive aspergil-
losis in murine recipients of allogeneic hematopoietic stem
cell transplants by activating IFNγ-producing T lymphocytes
[7]. Similarly, the adoptive transfer of Aspergillus-specific
Th1 cells conferred protection against invasive aspergillosis
in neutropenic mice that did not receive transplants [8]. There
is also accumulating evidence in humans that Th1 responses
provide protection against Aspergillus. In patients with
invasive aspergillosis, a predominant release of IFNγ in
culture supernatants on stimulation with A. fumigatus
antigens, which indicates a Th1 response, was associated
with a favorable outcome [9].
Mice deficient in the IFNγ receptor are also highly
susceptible to pulmonary cryptococcosis and display in-
creased lung fungal burdens and dissemination to the brain
[10]. IL-4/IL-13 double-knockout mice develop robust Th1
and Th17 responses in the absence of Th2 polarization [11].
When these mice are infected with Cryptococcus,t h e y
display significantly less fungal growth in the lungs than
wild-type mice. However, although systemic dissemination
was delayed in the IL-4/IL-13 double-knockout mice, the
infection progressed with a rate similar to the rate in the
wild-type mice. Thus, Th1 responses and Th17 responses
play an important role in clearing Cryptococcus from the
lungs, but they cannot prevent disseminated infection [11]. A
critical role for Th1 responses in the host defense against
Histoplasma capsulatum has been demonstrated by the fact
that CD4+ T cells from wild-type mice protect T cell–
deficient mice from Histoplasma infection, whereas CD4+ T
cells from IFNγ-deficient mice were unable to provide
protection [12]. Overall, these data demonstrate that Th1
responses play an important protective role during invasive
fungal infection.
Th17 Cells
The observation that mice deficient in IL-17RA (IL-17R-
deficient) show an increased susceptibility to disseminated
C. albicans infection first demonstrated the critical
involvement of Th17 responses in protective anti-Candida
host defenses [13]. In addition, mice deficient in Th17
responses were highly susceptible to oropharyngeal can-
didiasis [14￿]. Another recent study demonstrated that IL-
17A induced by dectin-2, a C-type lectin receptor (CLR)
that recognizes Candida mannans, is crucial for antifungal
host defense in disseminated candidiasis [15￿]. Although
these studies suggest a protective role for IL-17A and
Th17 responses in Candida infection, negative effects of
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albicans i n f e c t i o ni nm i c eh a v ea l s ob e e nr e p o r t e d[ 16].
Furthermore, mice that are deficient in Toll IL1R8 (TIR8),
which is a negative regulator of Th17 responses, show
higher susceptibility to Candida and Aspergillus infection
and have significantly more immunopathology [17]. On
the other hand, patients with impaired Candida-specific
Th17 responses, such as patients with chronic mucocuta-
neous candidiasis or hyper-IgE syndrome, are especially
susceptible to mucosal C. albicans infections [18￿￿, 19].
These observations strongly indicate that Th17 responses
are important for human anti-Candida mucosal host
defense. Th17 induction in response to Candida infection
is dependent on CLRs such as dectin-1, dectin-2, and
mannose receptor. Furthermore, dectin-1 and dectin-2
signal through the Syk-CARD9 pathway, and CARD9
was shown to be involved in Candida-induced Th17
responses. Recently, it was reported that patients with
genetic defects in dectin-1 or CARD9 suffer from chronic
mucosal fungal infections [20￿￿, 21￿￿]. Both dectin-1 and
CARD9 deficiency was shown to be associated with a
deficient fungal-induced IL-17 response. These data
further strengthen the crucial role of Th17 cells in human
antifungal mucosal defense.
Patients with chronic granulomatous disease (CGD) lack
NADPH oxidase activity and do not generate reactive
oxygen species. The result is recurrent bacterial and fungal
infections, especially fungal infections with Aspergillus.I t
has been reported that in the setting of deficient reactive
oxygen species generation in a mouse model of CGD, the
tryptophan metabolism in mice is deficient, which eventu-
ally results in increased IL-17 responses [22]. These
increased IL-17 responses were suggested to be detrimental
to the host when CGD mice were infected with Aspergillus.
In contrast, A. fumigatus does not stimulate strong
production of IL-17 in human cells, and human host
defenses against aspergillosis may rely on potent Th1
rather than Th17 responses [23].
It has also been suggested that the IL-17 pathway plays
an important role in Pneumocystis carinii infections.
Stimulation of alveolar macrophages with Pneumocystis
carinii induces IL-23 mRNA, and neutralization of IL-23 or
IL-17 increased disease severity during P. carinii infection
in wild-type mice [24]. Mice deficient in both Th1 and
Th17 responses show a much higher mortality when
infected with Cryptococcus than mice deficient in Th1
responses [25], indicating a protective role of Th17
responses in C. neoformans infection. In addition, mice
deficient in Toll-like receptor 2 (TLR2) that were infected
with Paracoccidioides braziliensis had an increased Th17
response, which was associated with protection [26]. In a
murine model of Histoplasma capsulatum infection, mice
deficient in the chemokine receptor CCR5 had a predom-
inant Th17 response and resolved the fungal infection more
efficiently then wild-type mice [27]. Overall, these data
indicate that fungi can induce Th17 responses and that the
IL-17 pathway plays an important role in protective
antifungal host defenses.
Th2 Cells
It is generally assumed that Th2 responses in fungal
infection are maladaptive or deleterious [28]. It has been
long recognized that an optimal balance between Th1 and
Th2 is important for antifungal protection. Oropharyngeal
candidiasis has been associated with a Th2 cytokine profile
in saliva [29]. A recent report highlights the importance of
the balance between protective Th1 responses and delete-
rious Th2 responses in disseminated candidiasis. Over-
expression of GATA-3, which is the master transcription
factor of Th2 cells, enhances the susceptibility to systemic
Candida infection, presumably by reducing the production
of IFNγ in response to Candida infection [30].
Frequent exposure to inhaled fungal spores presents a
challenge to the host, and aberrant immune responses to A.
fumigatus spores can result in allergic bronchopulmonary
aspergillosis (ABPA). ABPA is a disease in which Th2
CD4+ T-cell responses play a critical role in the develop-
ment of an asthma-like disease with pulmonary hypersen-
sitivity and compromised lung function. In patients with
allergic fungal rhinosinusitis, fungal antigens that stimulated
T-cell activation induced a predominantly Th2 immune
response [31]. Furthermore, administration of recombinant
IL-4 to mice leads to a significantly increased susceptibility
to invasive pulmonary aspergillosis, underscoring the dele-
terious effects of Th2 responses in systemic infections with
filamentous fungi [32]. Thus, Aspergillus-induced Th2
responses seem to contribute to ABPA and unfavorable
outcome in aspergillosis.
Interestingly, certain fungi have the capacity to modulate
T-helper responses. Melanin-producing Cryptococci, for
instance, can induce IL-4 and may in this way skew the
host defense towards a Th2 type of response [33]. This
alteration could be relevant during infection, because Th2
responses are reported to be deleterious in experimental
pulmonary cryptococcal infection [34]. In addition, a recent
study reported that the host response elicited by macro-
phages that are activated by prototypical Th2 cytokines is
associated with impaired defense against cerebral crypto-
coccosis [35]. Finally, in a model of experimental Histo-
plasma infection, an excess of IL-4 production and
increased Th2 responses were associated with delayed
clearance of H. capsulatum [36]. These studies show that
a predominant Th2 response during fungal infection is
generally associated with deleterious effects.
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Tregs suppress inflammatory responses in disseminated
candidiasis, and their presence during protective proin-
flammatory responses results in higher susceptibility to
disease in mice that are infected with C. albicans [37, 38].
At mucosal sites, however, the tolerance promoted by Tregs
seems to be beneficial, and it has been suggested that Tregs
have a role in allowing fungal persistence at the mucosal
site, which is beneficial for a continuous “state of alertness”
of the immune system and durable, protective antifungal
host response [39]. Notably, Tregs expand in disseminated
and gastrointestinal Candida infection. During Candida
infections, Tregs produce IL-4, IL-10, and TGF-β, which
inhibit inflammatory Th1 and Th17 responses [40]. On one
hand, Tregs restrict the capacity of the immune system to
control Candida infection, but on the other hand, they
augment host resistance to reinfection.
In experimental Aspergillus infection, Tregs that are
activated by Aspergillus conidia can control inflammation
by suppressing potentially deleterious effects of neutro-
phils through the actions of IL-10 on indoleamine 2,3-
dioxygenase [41]. Furthermore, Tregs can inhibit Th2
responses and in this way prevent allergic disease, which
may be induced by Aspergillus [41]. Tregs also control
pulmonary inflammation and protect against lung injury
associated with Pneumocystis infection in the setting of
immune reconstitution as well as during primary infection
[42]. The critical balance between proinflammatory
responses and Treg responses in fungal infection is further
underscored by the observation that a decrease in the
number of Tregs in mice infected with H. capsulatum is
associated with an increase in the Th17 response and more
efficient fungal clearance [27]. These data reflect that Treg
cells provide suppression of inflammatory responses,
which can be deleterious or beneficial, depending on the
type or stage of infection.
CD8+ Cytotoxic T Cells
A protective role of CD8+ T cells in the host defense
against mucosal candidiasis has been suggested. CD8+ T
cells can inhibit the growth of C. albicans hyphae in vitro
[43]. Furthermore, CD8+ T cells were important for
limiting chronic mucosal carriage of C. albicans in one
animal model of infection [44]. Notably, in the absence of
CD4+ T cells, CD8+ T cells also appear to play an
important role in anti-Candida host defense [44].
Studies that have investigated host defenses against other
fungi also suggest that CD8+ T cells may be protective.
IFNγ produced by CD8+ T cells was found to play an
important role in controlling cryptococcal infection by
limiting growth and survival of C. neoformans in macro-
phages, and these protective effects were independent of
CD4+ T cells [45]. The observation that CD8+ T cells can
provide protection in the absence of CD4+ T cells has also
been reported in H. capsulatum infection. Furthermore,
CD8+ T cells produce IFNγ in response to P. carinii and
mediate clearance of the fungal burden [46]. In conclusion,
although the role of CD8+ T cells has not been defined as
clearly as the role of T-helper responses, they can contribute
to protection against fungal pathogens in certain conditions.
γδ T Cells
Inadditiontothe describedT-cellsubsets,γδTcellsmayplay
animportant role in antifungalhostdefense byacting asa first
lineofdefense atthe mucosal level.Recently,itwasdescribed
thatγδTcells isolatedfromHIVpatientsandhealthycontrols
can proliferate and induce IFNγ and IL-17 in response to C.
albicans [47]. Because both IFNγ and IL-17 are important
for host defense against fungi, γδ T cells could represent an
important arm of the mucosal immunity against fungal
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Fig. 1 The interplay between T-cell subsets during antifungal host
defense. Antigen presenting cells (APCs) can polarize T helper (Th)
responses by generating specific cytokine profiles. Th1 and Th17 cells
play an important role in the recruitment and activation of neutrophils
that are crucial for an adequate host defense against fungal pathogens.
Th1 and Th17 can be inhibited by Th2 and/or T regulatory (Treg)
subsets, which can be beneficial in the setting of an exaggerated
immune response, but can be deleterious if a potent proinflammatory
response is necessary. IFNγ—interferon-γ;I L —interleukin; PMN—
polymorphonuclear cells
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intraperitoneal inoculation of C. albicans,a n dγδ T cells can
enhance NO production by macrophages in vitro. On the one
hand, in vivo depletion of γδ T cells abrogates inducible NO
synthase in the mucosa and enhances murine susceptibility to
candidiasis [48]. On the other hand, mice that are deficient in
γδ T cells are less susceptible to experimental Candida
vaginitis [49]. These data suggest that γδ T cells can
contribute to either protection against candidiasis or suscep-
tibility to it, depending on the site of the infection.
Notably, γδ T cells are responsible for the high IL-17
concentrations observed in CGD mice, as mentioned earlier
[22]. Interestingly, another subset of γδ T cells, which
produced IL-10 and TGF-β, was associated with protection
in the same model. These data suggest that γδ T cells can
exert important immunomodulatory functions during pul-
monary aspergillosis. Clearance of C. neoformans in the
lungs of mice was enhanced when mice were depleted of
γδ T cells [50]. The increased host defense was associated
with an increase in Th1 response in the lungs. These
observations suggest that γδ T cells can dampen proin-
flammatory responses during host defense against crypto-
coccal infection. Furthermore, human γδ T cells can
respond to Paracoccidioides brasiliensis and produce
factors that support the growth and differentiation of B
cells [51]. As observed above, relatively little is known
about the role of γδ T cells in antifungal host defense, and
the information is scattered. This aspect of antifungal host
defense certainly merits further investigation.
Conclusions
Summarizing these data, it has become evident that T cells
play a critical role in the host defense against fungi.
Although various functions have been described for the T-
cell subsets, in general Th1 and Th17 responses contribute
to protective antifungal defense, whereas Th2 responses can
be potentially deleterious in the setting of a fungal infection
(Fig. 1). Furthermore, it has become apparent that Tregs are
important in orchestrating the balance between T-cell
subsets, and thus Tregs can be good or bad for the host,
depending on how they modulate the immune response.
Finally, although the importance of cytotoxic Tcells and γδ
T cells in the host defense against fungi is not yet fully
understood, several studies suggest that they also contribute
to antifungal host defense. Specifically, γδ T cells may be
very important for the first line of defense against fungi at
the mucosal and epithelial level; more research is needed to
elucidate their importance in antifungal host defense.
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